Condition
Cirrhotic Cardiomyopathy clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Cirrhotic Cardiomyopathy clinical trials that are recruiting, at sites in 2 countries (most in India (3), United States (1)). By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 2Countries
Newest Cirrhotic Cardiomyopathy clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Cirrhotic Cardiomyopathy in Adults: A Prospective multicenter look | — | Nashville, Tennessee and 1 other locations | Recruiting | Jun 18, 2026 |
| Diastolic improvement with carvedilol and empagliflozin for people with cirrhosis | Phase 4 | Chandigarh | Recruiting | Jan 7, 2026 |
| Echocardiography-guided intensive care for septic shock in people with cirrhosis | — | Chandigarh | Recruiting | Dec 16, 2025 |
| Carvedilol plus simvastatin versus carvedilol alone for cirrhosis-related heart dysfunction | — | Chandigarh | Recruiting | May 29, 2024 |
All recruiting trials (4)
-
Cirrhotic Cardiomyopathy in Adults: A Prospective multicenter look
This study tests whether adults with decompensated cirrhosis often have hidden heart problems and whether bile acids in the blood are linked to those heart changes.
-
Diastolic improvement with carvedilol and empagliflozin for people with cirrhosis
This test will see if adding empagliflozin to carvedilol improves diastolic heart function and reduces decompensation events in adults with cirrhosis and left ventricular diastolic dysfunction.
-
Echocardiography-guided intensive care for septic shock in people with cirrhosis
This study will try using bedside ultrasound (POCUS) to guide fluid and blood-pressure treatment in adults with cirrhosis who develop sepsis-related low blood pressure.
-
Carvedilol plus simvastatin versus carvedilol alone for cirrhosis-related heart dysfunction
This trial will test whether adding simvastatin to carvedilol helps adults with cirrhosis and cirrhotic cardiomyopathy reduce liver decompensation and improve survival.
Related topics
Quick answers
How many Cirrhotic Cardiomyopathy clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in India (3 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.